Advanced Search

Publications > Journals > Gene Expression > About the journal

About the journal
Aims and Scope

Gene Expression (GE) is an open-access journal. It was launched in 1991 by Chicago Medical School Press, and transferred to Cognizant Communication Corporation in 1994. From August 2022, GE is published by Xia & He Publishing Inc.

GE publishes peer-reviewed and high-quality original articles, reviews, editorials, commentaries, and opinions on its primary research topics including cell biology, molecular biology, genes, and genetics, especially on the cellular and molecular mechanisms of human diseases.

GE has been indexed in Medline (1991-2021), Scopus, Biological Abstracts, Biosis Previews, ProQuest, etc.

Open Access

Gene Expression (GE) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

GE recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

Publication Criteria

All manuscripts submitted to GE must meet the following criteria for publication:

  • Topics with timely relevance to the general field or specialties in basic and clinical medicine;
  • Results and findings that have not been previously published elsewhere;
  • Research performed with adherence to accepted global standards for ethics in the scientific process;
  • Ethical reporting of data to protect the rights and privacy of study participants;
  • Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
  • Conclusions supported by the data presented;
  • All funding sources and their roles cited;
  • For clinical trials, the registration number cited;
  • Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
  • No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.
Publishing Schedule

GE currently publishes 4 issues a year.

Journal Metrics
GE Metrics (2023)
Acceptance rate: 19.9% 
Median time from submission to first decision: 27 days 
Median time from acceptance to online publishing: 30 days
Revenue Sources

GE adopts the open access publishing model. Revenues are generated from article processing charges, permission fees, and reprints.


GE is owned and published by Xia & He Publishing Inc.

Contact us
Editorial Office

Managing Editor: Yoko Ye
Postal Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China


Xia & He Publishing Inc.
Tel: +1-409-420-2868 

US Office
Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA

China Office
Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China
Back to Top